Connect with us

Health

COVID-19: Ontario reports 119 new cases, 7 in Ottawa; Premier Ford set to make announcement at Ottawa hospital – Ottawa Citizen

Published

 on


Ontario’s vaccination rollout has now reached 80.4 per cent of eligible (12-plus) residents with one dose, and 66.7 per cent have received both vaccine doses.

Article content

Ontario is reporting 119 new laboratory-confirmed COVID-19 cases and three related deaths Monday.

Advertisement

Article content

The province has now seen 549,447 total cases since the beginning of the pandemic and 9,316 people have died.

There are currently 96 patients in Ontario hospitals, with an additional 131 in intensive care units, and of those, 79 require a ventilator. (Ontario Public Health statistics of ICU hospitalizations and ventilator cases contain some patients who no longer test positive for COVID-19 but who are being treated for conditions caused by the virus. As such, occasionally, the number of patients in ICUs or that require a ventilator may exceed the number of patients in hospitals with COVID-19.)

Another 137 cases were resolved in the past 24 hours and of Ontario’s total case count, 538,702 are now considered resolved.

Advertisement

Article content

There were 11,930 tests conducted in the province Sunday with a 1.0 per cent positivity rate.

There were 22 cases identified in Toronto, 15 in Hamilton, 14 in Waterloo, and 13 in Peel region.

Officials in Ontario are also continuing to track the spread of variants of concern in the province.

There were 19 new confirmed cases of the Alpha variant, and there have now been 145,405 confirmed cases of that strain in Ontario.

Three new cases of the Delta variant were confirmed Monday, and there have now been 3,916 total cases of that variant in Ontario.

No new cases of the Beta or Gamma variant were identified in the province, according to Monday’s data.

Ontario’s vaccination rollout has now reached 80.4 per cent of eligible (12-plus) residents with one dose, and 66.7 per cent of residents have received both vaccine doses.

Advertisement

Article content

Another 65,920 vaccine doses were administered across the province on Sunday. As of 8 p.m. Sunday, 19,018,393 doses had been administered and 8,625,932 Ontarians had been fully immunized with both doses, according to the latest provincial data.

COVID-19 in Ottawa

Ottawa Public Health is reporting seven new cases in the city and no new deaths.

There have now been 27,782 total cases in Ottawa and of those, 27,147 are resolved. There have been 593 deaths attributed to COVID-19 in the city.

There are now 42 active cases in Ottawa, two fewer than Sunday, and there remains one patient in hospital, with none in ICU.

There have been 40 total cases of the Delta variant in Ottawa, according to provincial data.

There have also been 1,416,743 total vaccine doses administered in Ottawa.

Advertisement

Article content

According to OPH, 768,001 eligible residents (age 12-plus) have received one dose, and 638,520 are full vaccinated.

That represents 83 per cent of the eligible population with one dose and 69 per cent of the eligible population with both doses.

There was one new local case reported Sunday, and Ottawa has seen 27,775 total cases and 593 deaths, according to Sunday’s data.

Only one other case was identified Monday in the East region of the province, with one confirmed case in the Hatings region.

No new cases were identified in the Eastern Ontario public health unit, Kingston, Renfrew County or in Leeds, Grenville and Lanark.

Premier Doug Ford is in Ottawa Monday to make an announcement at the Ottawa Hospital’s General campus, where will be joined by Ottawa West-Nepean MPP Jeremy Roberts, Mayor Jim Watson, and Ottawa Hospital president and CEO Cameron Love.

Advertisement

Article content

The announcement is set for 1:15 p.m.

COVID-19 in Quebec

There have been 298 new cases in Quebec since the last provincial update on Friday, including 223 new cases over the weekend and 75 new cases confirmed Monday.

There have been 376,828 total cases in Quebec and 11,240 deaths. One new death was reported in Monday’s data.

Of those total cases, 364,774 people have recovered in Quebec and those cases are now considered resolved.

There are 67 patients in hospital in Quebec, which remains stable for the previous day’s figures, and there are 20 people in intensive care. That is one fewer than recent days.

Another 55,188 vaccine doses have been administered in the province, including 54,106 doses in the past 24 hours.

There have been 12,228,529 total vaccine doses administered in the province.

  1. CHEO chief of staff Dr. Lindy Samson says most of the children who have attended the Brewer assessment centre for testing did not have COVID-19, but they did have viruses — the kind that are common in children, but that almost disappeared during earlier stages of the pandemic.

    Resurgence of childhood viruses could strain ICUs, experts are warning

  2. Ottawa Dog Rescue adoption director Mike Gatta with his own dogs The Dood, 11 years.

    Supply and demand: Pandemic pets put pressure on rescue groups and vets

Advertisement

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Adblock test (Why?)



Source link

Continue Reading

Health

COVID-19 booster debate in US heads to FDA vaccine advisory committee – National | Globalnews.ca – Global News

Published

 on


The debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine moves to a panel of independent expert advisers to the U.S. Food and Drug Administration on Friday.

While U.S. health officials, some other countries and vaccine makers have said boosters are needed, many scientists and vaccine experts disagree.

The FDA staff said in documents prepared for the committee this week that the vaccine Pfizer Inc developed with Germany’s BioNTech SE is still very effective at preventing severe illness and death and that the evidence is mixed on whether its efficacy declines over time.


Click to play video: 'COVID-19: Boris Johnson reverses course on vaccine passports for England, announces UK booster program'



5:14
COVID-19: Boris Johnson reverses course on vaccine passports for England, announces UK booster program


COVID-19: Boris Johnson reverses course on vaccine passports for England, announces UK booster program

Pfizer, which is arguing for broad use of a third shot, submitted data from an analysis of over 300 participants in its late stage clinical trial showing that the vaccine’s efficacy diminished by around 6% every two months after the second dose, and that an additional shot boosted immunity.

The FDA’s Vaccines and Related Biological Products Advisory Committee will also consider data from Israel, which has been administering booster doses of the Pfizer/BioNTech vaccine.

It began offering a COVID-19 booster to people as young as age 12 last month, expanding a campaign that began in July for people over 60.

An analysis by Israeli scientists published on Wednesday in the New England Journal of Medicine found that among 1.1 million people age 60 or older who had been fully vaccinated at least 5 months earlier, those who received a booster were less likely to be infected or become severely ill than those who did not get the third shot.

Read more:
Unclear whether U.K.’s booster plan will mean new doses every 6 months, chief says

The Israeli Health Ministry said in documents on Friday that immunity against infection declined during July among all age groups, but particularly among people aged 60 and over who had been vaccinated in January.

Immunity against severe disease dropped in that older group, and such a decline may occur in younger groups aged 50 to 59 as well as 40 to 49, it said. The ministry also said the booster dose did not raise new safety issues.

The booster debate gained urgency as U.S. COVID-19 hospitalizations and deaths surged due to the highly transmissible Delta variant of the virus, mostly among the unvaccinated. But infections among fully vaccinated people have risen and they can spread the virus on occasion, mostly to unvaccinated people.


‘LARGER POPULATIONS MAY TAKE LONGER’

Wall Street analysts see the additional shots ultimately getting approved for a broad population.

“We expect a potential positive FDA support for boosters for elderly ahead of Biden’s rollout, but larger populations may take longer for broad support and approval,” Jefferies analyst Michael Yee said in an email.

Scientists say the strongest evidence for boosters is for older adults and other high risk populations.

“My guess is we are going to end up with a recommendation for booster doses for a certain subpopulation, such as adults older than 65,” said Bill Moss, executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.


Click to play video: 'Immunocompromised offered vaccine booster shot. Who is eligible?'



3:32
Immunocompromised offered vaccine booster shot. Who is eligible?


Immunocompromised offered vaccine booster shot. Who is eligible?

More than 1.9 million Americans have already gotten a booster dose after the government authorized them for people with compromised immune systems, according to the U.S. Centers for Disease Control and Prevention (CDC).

The panel will vote on if safety and effectiveness data support approval of a booster at least 6 months after the second dose for people aged 16 and older. The vote is scheduled for between 2:25 pm ET and 4:45 pm ET.

Eight top health officials in the Biden Administration – including the heads of the FDA and the CDC – said in August they believe booster shots will be needed because emerging data shows that protection against COVID-19 decreases over time.

Read more:
Moderna to take on COVID-19, flu with single booster vaccine

The U.S. is planning a booster campaign for the week of Sept. 20, contingent on backing by the FDA and CDC.

Moderna Inc has also asked for approval of a booster and released data on Wednesday showing that protection from its vaccine also wanes over time. That is not expected to be discussed at Friday’s meeting.

(Reporting by Manojna Maddipatla and Ankur Banerjee in Bengaluru; Editing by Caroline Humer and Bill Berkrot)

© 2021 Reuters

Adblock test (Why?)



Source link

Continue Reading

Health

'Absolutely gut-wrenching:' Waterloo Region child under the age of 10 dies after contracting COVID-19 – CP24 Toronto's Breaking News

Published

 on


A Waterloo Region child under the age of 10 has died after contracting COVID-19.

Dr. Hsiu-Li Wang, who serves as the medical officer of health for Waterloo Region, shared the news during a briefing on Friday.

She said that the child had underlying health conditions but did not provide any further information, other than to say that there were no “school-related or childcare-related exposures.”

“This is a heartbreaking loss and I wish to express my deepest sympathy and condolences to the family and loved ones,” she said.

Since the beginning of the pandemic there have only been five deaths reported in individuals under the age of 19 and Wang said that she was “not aware” of any other fatalities involving younger individuals in Ontario.

In a message posted to Twitter, Premier Doug Ford called the loss of someone so young “absolutely gut-wrenching.”

“My prayers are with the family at this excruciatingly difficult time,” he said. “This virus knows no bounds. It’s why we need every eligible Ontarian to get vaccinated — to protect ourselves, our loved ones, and those who can’t yet get vaccinated against COVID-19.”

With files from CTV News Kitchener

Adblock test (Why?)



Source link

Continue Reading

Health

88 new COVID-19 cases in Manitoba Friday; more than half not vaccinated – CTV News Winnipeg

Published

 on


WINNIPEG –

Manitoba has recorded 88 new COVID-19 cases in Manitoba, along with one more death added to the total.

According to the provincial COVID-19 dashboard, which was updated on Friday, of the new cases 53 were not vaccinated, 12 were partially vaccinated and 23 were fully vaccinated.

The new cases bring Manitoba’s total to 59,612, including 629 active cases and 57,779 recoveries. The five-day test positivity rate in the province is 2.6 per cent.

The number of deaths of people with COVID-19 increased by one on Friday, for a total of 1,204. The province did not release any details about this death.

As of Friday, the province said there are 72 people in hospital with COVID-19 including 37 people with active cases. Of those 37 people, 27 are not vaccinated, eight are partially vaccinated and two are fully vaccinated.

Of the seven people in ICU as of Friday with active COVID-19 cases, the province said six are unvaccinated and one is partially vaccinated.

Adblock test (Why?)



Source link

Continue Reading

Trending